Mark A. Glickman
2015
In 2015, Mark A. Glickman earned a total compensation of $867.4K as Chief Commercial Officer at Aralez Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $90,956 |
| Salary | $204,321 |
| Stock Awards | $362,464 |
| Other | $9,660 |
| Total | $867,401 |
Glickman received $362.5K in stock awards, accounting for 42% of the total pay in 2015.
Glickman also received $200K in bonus, $91K in non-equity incentive plan, $204.3K in salary and $9.7K in other compensation.
Rankings
In 2015, Mark A. Glickman's compensation ranked 8,617th out of 13,638 executives tracked by ExecPay. In other words, Glickman earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,617 out of 13,638 | 37th |
Division Manufacturing | 3,292 out of 5,187 | 37th |
Major group Chemicals And Allied Products | 1,198 out of 1,857 | 36th |
Industry group Drugs | 974 out of 1,531 | 36th |
Industry Pharmaceutical Preparations | 761 out of 1,179 | 36th |
Source: SEC filing on March 23, 2017.
Glickman's colleagues
We found three more compensation records of executives who worked with Mark A. Glickman at Aralez Pharmaceuticals in 2015.